Stay updated with breaking news from Klus Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Resear
Three early-phase clinical studies presented by researchers from The University of Texas MD Anderson Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2024 show promising initial data for patients with lymphoma, gastric or gastroesophageal junction cancers, and specific molecularly selected tumors.
CT141 mRNA-4157 Individualized Neoantigen Therapy +...
/PRNewswire/ -- DelveInsight's Medical Second Opinion Market Insights report provides the current and forecast market analysis, individual leading medical...
/PRNewswire/ -- DelveInsight's Bladder Cancer Market Insights report includes a comprehensive understanding of current treatment practices, bladder cancer...